Medication review by pharmacists can be an important educational intervention to improve adherence rates as it can potentially address many of its barriers. Medication review may also directly improve the patient's knowledge and understanding of his or her drug regimen. This study aims to assess the effectiveness of medication review as an intervention to improve a patient's knowledge and adherence to their chronic medications.
INTRODUCTION
Medication review is a structured, critical examination by a pharmacist of a patient's medications in relation to his or her health condition. It involves a tripartite partnership between the doctor, pharmacist and patient or caregiver with the aim of optimising the patient's medication therapy, identifying and resolving medication-related issues, and reducing waste 1 . Medication review provides a platform for the pharmacist to educate patients on the knowledge of their medicines through individualised counselling, to assess patients' adherence, and to address any concerns that they may have with regard to their medications, medical conditions and other issues related to their health.
Medication non-adherence can be a problem in the primary care setting due to the demographic development of increasing numbers of patients with chronic diseases requiring continuous polypharmacy 2, 3 . Patients with chronic diseases, who are non-adherence to their long-term pharmacotherapy, may not derive full benefit from their treatment and achieve the desired therapeutic outcomes [4] [5] [6] . Medication review Proceedings of Singapore Healthcare  Volume 23  Number 2  2014 can be an important educational intervention to improve adherence rates as it can potentially address many of its barriers. Medication review may also directly improve upon the patient's knowledge and understanding of his or her drug regimen, which can potentially lead to better medication adherence. However, there is no local data and limited international studies 7-14 currently to provide these evidences even as medication review services are widely available in pharmacy centres worldwide.
This research study was conducted with the aim to determine the effectiveness of medication review as an intervention to improve on patients' medication knowledge (defined as dosage, frequency, indication, storage condition and administration of medicine) and their adherence to their chronic medication in the primary care setting.
METHODS

Study design
This pilot study was conducted across four polyclinics providing primary care in the northeastern and central regions of Singapore from June to December 2012. The duration of study was determined based on the usual follow-up period (of within six months) required to resolve medication-related issues identified for patients who have been enrolled to receive medication review services. Approval was obtained from the SingHealth Central Institutional Review Board Ethics Committee before commencement of the study, and patient informed consent was obtained for participation in the study
Study sample
All polyclinic patients, who were referred for pharmacist-conducted medication review by prescribers due to issues with medication knowledge or adherence, were invited to participate in the study (i.e. consecutive sampling was employed) if they met the following eligibility criteria: they were at least 21 years of age, and were on polypharmacy with chronic medications (defined as having five or more medications being prescribed) 15, 16 . They were excluded from this study if they were perceived by the investigators to have cognitive impairment or language barriers, or if they had received prior medication review. The prescribers referring the patients were blinded to the study. Based on pre-test data, a minimum sample size of 130 patients was determined for the study, based on a probability level of 5% and desired power level of 80%.
Study instrument
A two-part questionnaire instrument was developed for the purpose of this study by the principal investigator, and all investigators were trained to administer the questionnaire in a standardised manner. The questionnaire solicited information on demographic characteristics, education level, employment and living status, medical and medication history, level of independence with regards to medication administration and use of medication aids.
A Medication Knowledge Index scoring system was used in the questionnaire to report the test results of the patient's knowledge on the dosage, frequency, indication, storage and administration method of their prescribed medication regimens. The patient's knowledge was quantified using the following formula: Medication adherence was measured using the Morisky Medication Adherence Scale (MMAS-4), which was applied in accordance with the study patient's language proficiency (in English or Mandarin). The MMAS-4 scale was selected based on published evidence of the theoretical correlation between the constructs it measures and medication adherence, as well as its ease of use [17] [18] [19] . The MMAS-4 consists of four questions with a scoring scheme of "Yes"=1 and "No"=0. The items are summed to give a range of scores from 0 to 4:
MMAS-4 score= 0 (High adherence)
MMAS-4 score= 1 to 2 (Intermediate adherence)
MMAS-4 score= 3 to 4 (Low adherence)
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The study investigators administered the questionnaire twice on the same patient; on the day of medication review before it was conducted, and on the patient's subsequent follow up visit.
Study intervention
The medication review intervention conducted by the polyclinic's attending pharmacist comprised a half-an-hour interview and counselling session with the study patient (with or without their caregivers) to identify and address medication-related issues. These were pharmacists who had received prior training on medication review based on a standard course programme. On the day of medication review, the attending pharmacist would document the patient's issues and care plan in the form of electronic medical records for communication with the referring physician. At the follow-up visit, the investigator would ensure that there were no other similar interventions being received by the study patients prior to administration of the questionnaire instrument.
Statistical methods
Statistical analysis was carried out using SPSS 21.0. Student's paired t-test and Chi-square test were used to determine the significance in relation to the change in patient's scores for medication knowledge and adherence respectively after medication review. Pearson's correlation was used to determine the relationship between medication knowledge and adherence scores. 
Medication adherence
Out of the 195 patients who completed the study, 29.7% (58 patients) attained a high adherence score (MMAS-4=0) before medication review was conducted and these patients continued to be adherent even after the intervention was applied.
Seventy point three percent (137 patients) of the participants reported non-adherence (MMAS-4 score of 1 to 4) to their chronic medications before medication review. However, this percentage was almost halved (to 36.9%) after they had received the intervention. There was also a significant decrease in the percentage of patients who had reported low adherence scores (27.7% to 5.8%), and a significant increase in the percentage of patients who reported high adherence scores (29.7% to 63.1%), after the medication review intervention (p<0.01; Table 2 ).
Association between medication knowledge and adherence
There was significant correlation between the patients' medication knowledge and adherence scores (p<0.001).
Multivariate analysis of educational level versus knowledge and adherence
A multivariate analysis of study patient's educational level affecting their results on medication knowledge and adherence was conducted (Tables  3 and 4 ). It was found that the younger patients were generally better educated (p<0.01). However, no correlation was found between the patients' educational level and their adherence to their medication regimens (p=0.964), or knowledge of their medications (p=0.059).
DISCUSSION
This study demonstrated the effectiveness of pharmacist-led medication review in improving the knowledge and adherence of primary care patients, especially the elderly, towards their chronic medications. This is important because adherence rates are typically lower among patients with chronic conditions, often dropping dramatically after the first six months of therapy 20, 21 . Medication nonadherence is also likely to grow as the population ages, and as patients take more medications to treat chronic conditions [22] [23] [24] . This study has shown that about 70% of the study population reported non-adherence to chronic medications at some point in time. This figure is higher than the rates (ranging from 30-60%) reported by the World Health Organisation 6 for developed countries, and it serves as an alert on the scale of the problem and the need for interventions to be put in place.
Medication review may be one way to establish a 'medication adherence contract' between healthcare providers and their patients at the onset of therapy as it sets out the medication plan and instructions to adhere to a long-term medication regimen in accordance to the physician's prescription 25 . It also serves to overcome adherence barriers by providing an avenue to resolve drugrelated issues, simplify complex medication regimens, recommend medication aids, provide individualised counselling, provide monitoring and feedback, and educate patients and caregivers 10, [26] [27] [28] [29] [30] [31] [32] . These factors could have contributed to the improvements in medication adherence scores as shown in this pilot study.
Poor adherence to chronic medication is detrimental to patient health outcomes and presents a big challenge to primary healthcare providers who are to treat many of such patients in a high volume environment [4] [5] [6] . It is imperative for primary care institutions to view medication nonadherence as a serious impediment to achieving better patient outcomes, and actively institute measures (such as medication review services) to detect and manage this issue in patients with chronic diseases. Research to quantify the impact to primary care patients' clinical outcomes as a result of poor medication adherence, or medication review intervention, will be conducted by our investigators in a study further to this.
This study found that medication review improved the medication knowledge indices of dose, frequency, indication, storage conditions and administration. This, in turn, may have led to the improved adherence scores (p<0.001).
It is important to reinforce such information to patients who are on multiple chronic medications as old age, slower response time and decreased cognitive function may worsen retention of the necessary instructions for medication-taking 20 . This is especially so in settings which do not have the luxury to allow for longer patient contact time 33 .
There are many methods to assess and measure medication adherence 18, 34 and knowledge 7, 35 . The medication knowledge index and MMAS-4 scoring scales were utilised as surrogate markers for indirect measurement of the patient's knowledge and adherence for this study, due to their ease of administration in our fast-paced primary care setting. However, we would like to highlight that the MMAS-4 scale and its translated Mandarin versions are not validated tools in our local setting, although it has been used in many adherence studies worldwide. Moving forward, we will need to assess its effectiveness in measuring a patient's adherence state across time. Similarly, future studies can explore the development of a validated knowledge assessment tool to assess patient's medication knowledge or literacy, which can be incorporated into medication review services. 
Study limitations
This research study did not set out to include a control group as we could not ethically reject patients who were referred by their physicians for medication review services. In addition, we could not include patients who were unable to converse in the spoken languages of the investigators, or who were cognitively impaired. It is uncertain if medication review intervention is effective in improving medication knowledge and adherence in such patient groups. The point measurements of knowledge indices and medication adherence scores were taken across two medication review visits, which were on average 12 weeks apart. A longer term study to determine the sustainability of improvements in knowledge and adherence scores is required.
CONCLUSION
Pharmacist-led medication review can be an effective intervention in the primary care setting to improve on medication knowledge and adherence in elderly patients on chronic medications. However, further study demonstrating the effectiveness of medication review in cultivating knowledge retention and sustained adherence in the longer-term is warranted.
